Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) System
CompletedOBSERVATIONAL
Enrollment
16
Participants
Timeline
Start Date
May 31, 2015
Primary Completion Date
January 25, 2019
Study Completion Date
January 25, 2019
Conditions
Breast Cancer
Interventions
DEVICE
MR-compatible scinti-mammography (MRI-SMM) system
Trial Locations (1)
92697
University of California, Irvine
All Listed Sponsors
lead
University of California, Irvine
OTHER
NCT02690805 - Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) System | Biotech Hunter | Biotech Hunter